2016 American Transplant Congress
Everolimus/Low Tacrolimus(TAC) Compared to MPA/RegularTAC for Renal Transplantation in the Elderly Recipient – Preliminary Analysis of the nEverOld Trial.
In the last decade, elderly patients (≥60y) have been more frequently listed for renal transplantation. From 2007 to 2014 the percentage of elderly renal transplant…2016 American Transplant Congress
A Users Guide to Maximizing Utility and Outcome in >70 Year Old Donors.
Liver Transplant & HPB Surgery, Weill Cornell Medical College, NY, NY.
Background Among 10 million stroke fatalities in the US since 2002, donated livers were recovered from 28,313. Unfortunately, only 2,402 livers were yielded from 7.5…2016 American Transplant Congress
Outcomes of Donor Nephrectomy in the Elderly.
PURPOSE: The critical organ shortage has increased demand for marginal donor kidneys. Although previously a contraindication to live kidney donation, advanced age donors (>60 y.o.)…2016 American Transplant Congress
Infectious Complication in Extremely Elderly Kidney Transplant (KT) Recipients: A Leading Cause of Death.
Introduction: The incidence of infection after KT have been reported to directly increase with recipient's age, likely due to the combined effect of co-morbidities and…2016 American Transplant Congress
Acute Rejection Profoundly Impacts Graft Survival in Young but Not in Old Kidney Transplant Recipients.
Background: The proportion of marginal grafts and elderly recipients awaiting kidney transplantation is ever increasing. The correlation of age with DGF and acute rejection determines…2015 American Transplant Congress
Effect of Induction in Renal Transplant Recipients Aged 70 and Over
Transplantation, Montefiore Medical Center, Bronx, NY.
While there is a significant survival advantage to transplanting patients 70 years of age and older versus staying on dialysis, it is unclear whether sensitized…2015 American Transplant Congress
Efficacy, Safety and Pharmacokinetics of Once-Daily, MeltDose® Tacrolimus (Envarsus® XR) Versus Twice-Daily Tacrolimus (Prograf®) in De Novo Kidney Transplant Recipient Sub-Groups: A 2 Year Phase 3 Randomized, Double-Blind, Double-Dummy, Trial
Differences in tacrolimus (tac) metabolism are evident in certain populations; in particular, lower tac bioavailability has been shown in females and black kidney transplant recipients…2015 American Transplant Congress
Excellent Outcomes With Kidney Transplantation for Patients ≥70 Years of Age
BackgroundOur aim was to determine the outcomes following kidney transplantation in recipients ≥70 years of age at the time of transplantation.Materials and MethodsWe analyzed data…2015 American Transplant Congress
Elderly Transplant Recipients Have Improved Graft Survival
Background: The upper age limit to receive a kidney transplant has progressively risen, but the outcomes of elderly (ages > 70) transplant recipients remain understudied.…2015 American Transplant Congress
Kidney Transplantation in the Septuagenarian
Department of Transplantation, Mayo Clinic, Jacksonville, FL.
The elderly ESRD population in the US continues to grow. National data demonstrates that both patient (PS) and graft survival (GS) at 1 and 5…
American Transplant Congress abstracts